SCHEMBL13190848

SCHEMBL13190848

CCOC(=O)CNC(=O)NCc1ccc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPID Q08752 4/20 0.56
PPIB P23284 1/20 0.53
PPIA P62937 1/20 0.53
PPIG Q13427 1/20 0.53
ALDH1A1 P00352 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
NLRP1 Q9C000 1/20 0.51
HTT P42858 1/20 0.50
GAA P10253 1/20 0.49
EPHX2 P34913 1/20 0.48
IDH1 O75874 1/20 0.47
NPC1 O15118 1/20 0.47
ALOX15 P16050 1/20 0.47
P2RX7 Q99572 3/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8744815 0.85 GAA (0.56) ALDH1A1TDP1HTTGAANPC1
SCHEMBL20595707 0.82 HTT (0.44) PPIDPPIBPPIAPPIGALDH1A1
SCHEMBL28224249 0.82 SMN1; SMN2 (0.58) ALDH1A1TDP1LMNAMAPK1NLRP1
SCHEMBL2041585 0.81 PPID (0.74) PPIDPPIBPPIAPPIGALDH1A1
SCHEMBL13702298 0.79 POLB (0.57) ALDH1A1TDP1LMNAMAPK1NLRP1
SCHEMBL2038799 0.79 PPID (0.71) PPIDPPIBPPIAPPIGALDH1A1
SCHEMBL23419468 0.78 CYP3A4 (0.43) PPIDPPIBPPIAPPIGALDH1A1
SCHEMBL20595706 0.78 CYP3A4 (0.43) PPIDPPIBPPIAPPIGALDH1A1
SCHEMBL13701827 0.78 ALDH1A1 (0.53) ALDH1A1LMNAMAPK1NLRP1HTT
SCHEMBL2039422 0.78 PPID (0.65) PPIDPPIBPPIAPPIGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010104307-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING DISEASES CAUSED BY THE TRANSLOCATION OF GSK3 FROM THE CELL NUCLEUS TO THE CYTOPLASM, CONTAINING COMPOUNDS FOR INHIBITING THE TRANSLOCATION OF GSK3 FROM THE CELL NUCLEUS TO THE CYTOPLASM 주식회사 메디젠텍 (KR) 2010-09-16 WO disclosed